Nektar Therapeutics (NKTR)

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $90.17M in the twelve months ending March 31, 2024, with 1.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $21.64M with 0.21% year-over-year growth. In the year 2023, Nektar Therapeutics had annual revenue of $90.12M.

• Revenue (ttm): $90.17M
• Revenue Growth: +1.51%
• P/S Ratio: 2.84
• Revenue / Employee: $658,153
• Employees: 137
• Market Cap: 255.79M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.92M	38.30M	33.41%
Dec 31, 2019	114.62M	-1.08B	-90.40%
Dec 31, 2018	1.19B	885.61M	287.81%
Dec 31, 2017	307.71M	142.28M	86.00%
Dec 31, 2016	165.44M	-65.35M	-28.32%
Dec 31, 2015	230.78M	30.08M	14.99%
Dec 31, 2014	200.71M	51.79M	34.77%
Dec 31, 2013	148.92M	67.73M	83.42%
Dec 31, 2012	81.19M	9.71M	13.59%
Dec 31, 2011	71.48M	-87.56M	-55.06%
Dec 31, 2010	159.04M	87.11M	121.10%
Dec 31, 2009	71.93M	-18.25M	-20.24%
Dec 31, 2008	90.19M	-182.84M	-66.97%
Dec 31, 2007	273.03M	55.31M	25.40%
Dec 31, 2006	217.72M	91.44M	72.41%
Dec 31, 2005	126.28M	12.01M	10.51%
Dec 31, 2004	114.27M	8.01M	7.54%
Dec 31, 2003	106.26M	11.41M	12.03%
Dec 31, 2002	94.85M	17.38M	22.43%
Dec 31, 2001	77.47M	25.84M	50.05%
Dec 31, 2000	51.63M	10.27M	24.83%
Dec 31, 1999	41.36M	19.56M	89.76%
Dec 31, 1998	21.80M	5.55M	34.13%
Dec 31, 1997	16.25M	9.36M	135.83%
Dec 31, 1996	6.89M	3.45M	100.00%
Dec 31, 1995	3.45M	1.79M	108.66%
Dec 31, 1994	1.65M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.